1. Home
  2. OGN vs VCYT Comparison

OGN vs VCYT Comparison

Compare OGN & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

N/A

Current Price

$13.89

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Logo Veracyte Inc.

VCYT

Veracyte Inc.

N/A

Current Price

$24.43

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OGN
VCYT
Founded
1923
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.2B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
OGN
VCYT
Price
$13.89
$24.43
Analyst Decision
Hold
Buy
Analyst Count
4
12
Target Price
$10.33
★ $44.60
AVG Volume (30 Days)
2.3M
★ 2.5M
Earning Date
10-30-2026
11-04-2026
Dividend Yield
★ 0.58%
N/A
EPS Growth
N/A
★ 164.52
EPS
★ 1.56
1.04
Revenue
★ $6,216,000,000.00
N/A
Revenue This Year
N/A
$14.27
Revenue Next Year
$2.07
$7.83
P/E Ratio
★ $8.91
$23.59
Revenue Growth
N/A
★ N/A
52 Week Low
$5.69
$21.91
52 Week High
$13.90
$60.91

Technical Indicators

Market Signals
Indicator
OGN
VCYT
Relative Strength Index (RSI) 64.32 28.37
Support Level $13.72 $21.91
Resistance Level N/A $34.72
Average True Range (ATR) 0.05 2.65
MACD 0.01 -2.50
Stochastic Oscillator 90.63 8.00

Price Performance

Historical Comparison
OGN
VCYT

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Share on Social Networks: